Deep learning identifies antimicrobial peptides hidden in prion-related proteins
APEX 1.1 screened 19.3 million peptide fragments from 2,897 prion-related proteins and identified 1,179 candidate antimicrobial peptides, termed prionins. Among 75 synthesized candidates, 59 inhibited at least one tested bacterial strain; two selected peptides reduced Acinetobacter baumannii burden in a mouse skin-abscess model. The study shows that prion-related sequences can yield experimentally active antimicrobial fragments, but does not show that these peptides are naturally released or function as host-defense agents in their source organisms.
Technology: APEX 1.1 deep-learning antimicrobial-peptide prediction and prioritization
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: Of 75 synthesized APEX-selected prionins, 59 inhibited at least one bacterial strain in vitro; two selected peptides reduced A. baumannii burden in a mouse skin-abscess model.
- Still unknown: No evidence shows these fragments are naturally released from their source proteins or physiologically function as host-defense peptides in native organisms. Mouse results do not establish human efficacy or safety.
- AI role: APEX 1.1 scored peptide fragments for predicted antimicrobial activity and prioritized candidates from a search across prion-related proteins for synthesis and experimental screening.
Evidence sources: https://www.nature.com/articles/s41564-026-02408-1
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 17 Nov 2026. Review scope: Primary Nature Microbiology full text as indexed, including methods, results, author contributions and affiliations..
Editorial assessment: Impact 4/5 · Validation 3/5 · Novelty 4/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.